Liver Cancer

Protocols
7 protocols meet the specified criteria
Disease Site: Liver
Protocol No. Title
13631 Molecular Analysis for Therapy Choice (MATCH)
14006 A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects with Hepatocellular Carcinoma Who Have Received Prior Sorafenib
14527 A Phase 3 Randomized, Open-Label Study Comparing Pexa-Vec (Vaccinia GM-CSF/Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy
15092 An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors
15562 A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma
15873 A Phase 1/2 study exploring the safety, tolerability, and efficacy of INCAGN01876 in combination with immune therapies in subjects with advanced or metastatic malignancies
16016 DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors